Investigating the role of practice nurses in the early identification and management of chronic kidney disease in the general practice setting: An integrative review

Aim The aim of this study was to critically review research literature investigating the role of practice nurses in the early identification and management of chronic kidney disease (CKD) in the general practice setting. Method An integrative review was performed to determine the extent to which the topic has been investigated. Quantitative and qualitative research papers were systematically located in peer-reviewed journals in electronic databases. Included papers were critically appraised using the relevant CASP appraisal tools. Findings There is a paucity of research investigating the role of practice nurses in the early identification and management of CKD in primary health care. Three articles published between 2013 and 2017 were identified: two quantitative studies and one qualitative study. One study from The Netherlands quantified positive outcomes of practice nurse-centred management of CKD in general practice. Conclusion Practice nurses may be effective in the early identification and management of CKD, including improving blood pressure control. Providing education to practice nurses appears to be a key factor in increasing practice nurses’ involvement in identification and management of CKD. Further research is warranted to see if the results are transferable to other jurisdictions.

Download Full-text

What practice nurses need to know about the NICE chronic kidney disease guidelines

Practice Nursing ◽

10.12968/pnur.2021.32.12.468 ◽

2021 ◽

Vol 32 (12) ◽

pp. 468-472

Author(s):

Peter Ellis

Keyword(s):

Chronic Kidney Disease ◽

General Practice ◽

Kidney Disease ◽

Kidney Function ◽

Practice Nurse ◽

Nice Guidelines ◽

Practice Nurses ◽

Health Related ◽

The Uk

Chronic kidney disease is highly prevalent in the community. Peter Ellis looks at the role of the practice nurse in diagnosing and managing chronic kidney disease in general practice Chronic kidney disease (CKD) is defined as a reduction in kidney function, or damage to kidney structure, which has persisted for greater than 3 months and which is associated with other health-related issues. While there are many causes of CKD, the most prevalent in western societies, including the UK, are diabetes and hypertension. This article identifies the role of the practice nurse in applying the National Institute for Health and Care Excellence (NICE) guidelines for CKD.

Download Full-text

An evaluation of general practice nurses' knowledge of chronic kidney disease risk factors and screening practices following completion of a case study-based asynchronous e-learning module

Australian Journal of Primary Health ◽

10.1071/py18173 ◽

2019 ◽

Vol 25 (4) ◽

pp. 346

Author(s):

Peter M. Sinclair ◽

Ashley Kable ◽

Tracy Levett-Jones ◽

Carl Holder ◽

Christopher J. Oldmeadow

Keyword(s):

Risk Factors ◽

Chronic Kidney Disease ◽

General Practice ◽

Kidney Disease ◽

Disease Risk ◽

Practice Nurses ◽

Learning Module ◽

Chronic Kidney Disease Risk ◽

E Learning ◽

Nurses Knowledge

National and international guidelines recommend opportunistic screening for chronic kidney disease to allow for early detection and management. Despite these guidelines, screening for chronic kidney disease in general practice settings is often suboptimal. This paper reports the results of a study that evaluated: (a) the effect of an asynchronous web-based e-learning module on general practice nurses’ knowledge about chronic kidney disease risk factors and screening practices; and (b) general practice nurses’ perceived satisfaction with the e-learning module. Changes in chronic kidney disease knowledge were assessed using a pre-test and post-test evaluative design, and satisfaction scores were measured on completion of the module. Participants’ baseline knowledge scores were poor, with mean pre-test scores of 3.77 (s.d. 1.66) out of 10. Post-test scores revealed a significant improvement (mean difference 1.81, (95% CI: 1.53 – 2.09), P < 0.01); however, overall final scores remained inadequate. Participants highly rated their satisfaction with the design of the module. Our results suggest that an asynchronous web-based e-learning module can improve general practice nurses’ knowledge about chronic kidney disease risk factors and screening practice. Efforts are required to increase practice nurses’ access to educational opportunities designed to improve knowledge in this area with the aim of increasing opportunistic screening for chronic kidney disease in the general practice setting.

Download Full-text

Barriers and facilitators to opportunistic chronic kidney disease screening by general practice nurses

Nephrology ◽

10.1111/nep.12856 ◽

2017 ◽

Vol 22 (10) ◽

pp. 776-782 ◽

Cited By ~ 8

Author(s):

Peter M Sinclair ◽

Jenny Day ◽

Tracy Levett-Jones ◽

Ashley Kable

Keyword(s):

Chronic Kidney Disease ◽

General Practice ◽

Kidney Disease ◽

Disease Screening ◽

Barriers And Facilitators ◽

Practice Nurses

Download Full-text

THE ROLE OF THERAPEUTIC EDUCATION FOR HYPERTENSIVES IN THE GENERAL PRACTICE SETTING: PP.20.267

Journal of Hypertension ◽

10.1097/01.hjh.0000379193.85292.ff ◽

2010 ◽

Vol 28 ◽

pp. e327-e328

Author(s):

M DʼAvino ◽

D Scala ◽

S Cozzolino ◽

B Andria ◽

R Fogliamanzillo ◽

...

Keyword(s):

General Practice ◽

Therapeutic Education ◽

Practice Setting ◽

General Practice Setting

Download Full-text

Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers

Al Mustansiriyah Journal of Pharmaceutical Sciences ◽

10.32947/ajps.20.01.0442 ◽

2020 ◽

pp. 82-94

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Pharmaceutical Care ◽

Biochemical Parameters ◽

Positive Impact ◽

Potential Effect ◽

Care Group ◽

Mineral Bone Disorder ◽

Bone Disorder

Objective: the present study was aimed to evaluate the role of pharmaceutical services in improving the outcome of mineral bone disorder in patients with advanced chronic kidney disease. Methodology: One hundred and twenty patients with chronic kidney disease-mineral bone disorder (CKD-MBD) screened for eligibility, seventy-six patients enrolled in the study and randomly allocated into two groups: pharmaceutical care and usual care, both groups interviewed by the pharmacist using specific questionnaire for assessing the quality of life (QoL). All the drug related problems (DRPs) including drug-drug interactions (DDIs) were recorded by the pharmacist. Blood samples were collected and utilized for analyzing the levels of vitamin D, phosphorous, calcium, albumin and parathyroid hormone at baseline and three months after. The pharmaceutical care group received all the educations about their medications and how to minimize DRPs; improve the QoL. Additionally, the pharmaceutical intervention included correcting the biochemical parameters. Results: Pharmaceutical care significantly improved patients QoL and minimized DRPs and DDIs. It was also effective in improving the biochemical parameters. Conclusion: Pharmaceutical care has a positive impact on improving the outcome of patients with CKD-MBD through attenuating DRPs, improving the biochemical parameters and the QoL.

Download Full-text